0001209191-19-007772.txt : 20190206
0001209191-19-007772.hdr.sgml : 20190206
20190206164953
ACCESSION NUMBER: 0001209191-19-007772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190205
FILED AS OF DATE: 20190206
DATE AS OF CHANGE: 20190206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aker Christopher Ray
CENTRAL INDEX KEY: 0001762611
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 19572075
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-05
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001762611
Aker Christopher Ray
C/O REGULUS THERAPEUTICS
10614 SCIENCE CENTER DR.
SAN DIEGO
CA
92121
0
1
0
0
Sr. VP & General Counsel
Common Stock
2019-02-05
4
A
0
25000
0.00
A
27747
D
Stock Option (Right to Buy)
0.95
2019-02-05
4
A
0
25000
0.00
A
2029-02-04
Common Stock
25000
25000
D
Restricted Stock Units which vest ratably on a quarterly basis such that the grant is fully vested on December 31, 2019, subject to the reporting person's continuous service to Regulus through each such vesting date.
The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Christopher Aker
2019-02-06